D.C. Diagnosis: Trump’s approach to health care, Sarepta’s lobbyists
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health…
Vinay Prasad returns to the FDA, weeks after his ouster
WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine,…
Voluntary pressure: Mixed results from Trump’s health approach
WASHINGTON — The Trump administration’s unprecedented approach to overseeing the health industry seems to be working — at…
Health Care Inc.: MAGA backs Medicare, faux drug price transparency
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Can San Diego biotech bounce back from slump?
SAN DIEGO — Ever since Vince Kato was laid off, he has felt like he was just two…
Senate committee rejects NIH cuts, boosts budget by $400 million
WASHINGTON — Senators from both parties endorsed a $400 million increase to the budget of the National Institutes…
Health care, tech companies promise to make patient data more accessible
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
White House blocks NIH from awarding any research grants
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT…
Vinay Prasad departs FDA | STAT
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
Trump order on ‘woke AI’ endangers science, weaponizes DEI
In late July, President Trump signed three executive orders relating to artificial intelligence as part of the administration’s…